Index | Ligand Name | Structure | PDB code | Compound Potency nM |
1 | b96 | Human p38 MAP Kinase in Complex with BIRB 796 | 1kv2 | 0.1 |
2 | 084 | The structure of p38 alpha in complex with a pyridinylimidazole inhibitor | 1ouk | 0.13 |
3 | p38 | Morpholino pyrrolotriazine P38 Alpha map kinase inhibitor compound 30 | 3bv2 | 0.44 |
4 | p39 | Morpholino pyrrolotriazine P38 Alpha Map Kinase inhibitor compound 2 | 3bv3 | 0.46 |
5 | b45 | The structure of p38alpha in complex with a dihydroquinazolinone | 3gc7 | 0.6 |
6 | 358 | The structure of p38 alpha in complex with a dihydroquinolinone | 1ove | 0.74 |
7 | yiw | triazolopyridine inhibitors of p38 kinase | 2yiw | 0.8 |
8 | a17 | P38 complex with a phthalazine inhibitor | 3ds6 | 0.8 |
9 | mih | p38 kinase Crystal structure in complex with small molecule inhibitor | 3mw1 | 0.82 |
10 | f46 | Human p38 MAP kinase in complex with a Dibenzoxepinone | 4l8m | 1 |
11 | 09j | Crystal Structure of p38a Mitogen-Activated Protein Kinase in Complex with a Triazolopyridazinone inhibitor | 3u8w | 1 |
12 | i2o | p38 kinase crystal structure in complex with small molecule inhibitor | 3rin | 1.3 |
13 | hb9 | Dibenzosuberone inhibitor 8e in complex with p38 MAPK | 5mty | 1.3 |
14 | p66 | Crystal Structure of p38a Mitogen-Activated Protein Kinase in Complex with a Pyrazolopyridazine Inhibitor | 3itz | 1.4 |
15 | 3ff | Human p38 MAP Kinase in Complex with Skepinone-L | 3que | 1.5 |
16 | p40 | P38 Complexed with a quinazoline inhibitor | 3dt1 | 2.4 |
17 | dqo | Crystal structure of p38 MAP kinase in complex with a dihydroquinazolinone inhibitor | 1m7q | 2.6 |
18 | ocg | P38 Alpha kinase complexed with a 5-amino-pyrazole based inhibitor | 3ocg | 3 |
19 | 279 | Phenylalanine pyrrolotriazine p38 alpha map kinase inhibitor compound 11B | 2rg5 | 3.1 |
20 | p37 | Crystal Structure of p38a Mitogen-Activated Protein Kinase in Complex with a Pyrazolopyridinone Inhibitor | 3gfe | 3.2 |
21 | yix | Triazolopyridine Inhibitors of p38 | 2yix | 3.3 |
22 | 304 | P38 alpha map kinase complexed with BMS-640994 | 3bx5 | 3.5 |
23 | 39p | P38 Alpha Map Kinase complexed with pyrrolotriazine inhibitor 7V | 3mvm | 3.9 |
24 | 1pp | p38alpha bound to pyrazolourea | 2baj | 4 |
25 | nk0 | P38 alpha kinase complexed with a pyrazolo-triazine based inhibitor | 3s4q | 4 |
26 | 094 | The structure of p38 alpha in complex with a dihydropyrido-pyrimidine inhibitor | 1ouy | 4.3 |
27 | gk6 | Crystal structure of P38 kinase in complex with a biphenyl amide inhibitor | 3d83 | 4.4 |
28 | 1m8 | Crystal structure of mitogen-activated protein kinase 14 (P38-H5) complex with 5-(2-CHLOROPHENYL)-N-(5-(CYCLOPROPYLCARBAMOYL)-2-METHYLPHENYL)-2-THIOPHENECARBOXAMIDE | 4kin | 4.8 |
29 | tzy | Crystal structure of P38 with triazolopyridine | 1zzl | 5 |
30 | 79q | Human p38 MAP Kinase in Complex with Dibenzosuberone Compound 1 | 5tco | 6.46 |
31 | aav | P38ALPHA MAP KINASE BOUND TO CMPD 29 | 4aac | 6.7 |
32 | 1r9 | Crystal structure of mitogen-activated protein kinase 14 (P38-H5) complex with 2-(2-CHLOROPHENYL)-N-(5-(CYCLOPROPYLCARBAMOYL)-2-METHYLPHENYL)-1,3-THIAZOLE-5-CARBOXAMIDE | 4kip | 7 |
33 | sb4 | Structural basis of autoactivation of p38 alpha induced by TAB1 (Monoclinic crystal form) | 4loo | 7 |
34 | sb4 | Structural basis of autoactivation of p38 alpha induced by TAB1 (Tetragonal crystal form) | 4lop | 7 |
35 | sb4 | Structural basis of autoactivation of p38 alpha induced by TAB1 (Tetragonal crystal form with bound sulphate) | 4loq | 7 |
36 | 3nw | P38 Alpha kinase complexed with a 2-aminothiazol-5-yl-pyrimidine based inhibitor | 3nww | 7 |
37 | 6np | Crystal Structure of p38 Alpha in Complex with a Selective Pyridazine Inhibitor | 1yqj | 7.3 |
38 | 469 | Human p38 MAP Kinase in Complex with Scios-469 | 3hub | 8.2 |
39 | edd | Crystal structure of P38 alpha in complex with DP802 | 3nnw | 9 |
40 | qc0 | P38ALPHA MAP KINASE BOUND TO CMPD 22 | 4aa4 | 9 |
41 | 1vi | Human p38alpha MAPK in complex with imidazolyl pyridine inhibitor 11b | 5ml5 | 10 |
42 | n4d | P38 alpha kinase complexed with a pyrazolo-pyrimidine based inhibitor | 3l8x | 10 |
43 | edd | Crystal structure of phosphorylated P38 alpha in complex with DP802 | 3nnx | 11 |
44 | sb2 | Dual binding mode of pyridinylimidazole to MAP kinase p38 | 2ewa | 11.5 |
45 | gk5 | Crystal Structure of P38 Kinase in Complex with a biphenyl amide inhibitor | 3d7z | 12 |
46 | lgf | P38 Alpha Map Kinase inhibitor based on heterobicyclic scaffolds | 2qd9 | 13 |
47 | li9 | Crystal Structure Analysis of inactive P38 kinase domain in complex with a Monocyclic Pyrazolone Inhibitor | 1ywr | 13 |
48 | 38p | P38 Alpha Map Kinase complexed with pyrrolotriazine inhibitor 7K | 3mvl | 13 |
49 | sb2 | Human P38 MAP Kinase in Complex with SB203580 | 3gcp | 15 |
50 | cq0 | p38 kinase crystal structure in complex with small molecule inhibitor | 3s3i | 16 |
51 | nqb | P38ALPHA MAP KINASE BOUND TO CMPD 33 | 4aa5 | 16 |
52 | fs8 | Human p38 MAP Kinase in Complex with a Dibenzosuberone Derivative | 3uvq | 17 |
53 | fji | Dibenzooxepinone inhibitor 12b in complex with p38 MAPK | 5mtx | 17.7 |
54 | p7b | p38 inhibitor-bound | 3p7b | 18 |
55 | sb4 | THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB220025 | 1bl7 | 19 |
56 | i39 | p38 kinase Crystal structure in complex with small molecule inhibitor | 3hrb | 21 |
57 | p7c | p38 inhibitor-bound | 3p7c | 22 |
58 | i47 | Crystal Structure of Human p38alpha complexed with SD-0006 | 3hl7 | 23 |
59 | 1ra | Crystal structure of mitogen-activated protein kinase 14 (P38-H5) complex with ETHYL 6-((5-(CYCLOPROPYLCARBAMOYL)-2-METHYLPHENYL)CARBAMOYL)-1H-INDOLE-1-CARBOXYLATE | 4kiq | 23 |
60 | sb5 | THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB218655 | 1bmk | 25 |
61 | g11 | Crystal structure of p38 in complex with a biphenylamide inhibitor | 3iph | 25.1 |
62 | aa0 | P38ALPHA MAP KINASE BOUND TO CMPD 2 | 4aa0 | 35 |
63 | 048 | Human p38 MAP Kinase in Complex with a Benzamide Substituted Benzosuberone | 3uvp | 35 |
64 | aqz | p38alpha MAP kinase bound to MPAQ | 2bak | 37 |
65 | l9g | Crystal Structure of Human p38alpha Complexed With a Triazolopyrimidine compound | 3kf7 | 40 |
66 | sb2 | THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB203580 | 1a9u | 48 |
67 | edb | Crystal structure of P38 alpha in complex with DP1376 | 3nnu | 48 |
68 | bax | Human P38 MAP kinase in complex with Sorafenib | 3gcs | 56 |
69 | l11 | p38 Kinase crystal structure in complex with small molecule inhibitor | 1w83 | 65 |
70 | p5k | P38 inhibitor-bound | 3p5k | 76 |
71 | bff | Human p38 MAP Kinase in Complex with CP-547632 | 3l8s | 99 |
72 | 2a8 | Human p38 MAP Kinase in Complex with 2-amino-phenylamino- dibenzosuberone | 3zya | 100 |
73 | 3gf | Crystal structure of p38 alpha MAP kinase in complex with a novel isoform selective drug candidate | 4r3c | 101 |
74 | p78 | P38 inhibitor-bound | 3p78 | 110 |
75 | pgj | Mutated Mus Musculus P38 Kinase (mP38) | 1yw2 | 141 |
76 | sb6 | THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995 | 1bl6 | 160 |
77 | bax | P38 in complex with Sorafenib | 3heg | 180 |
78 | l10 | p38 Kinase crystal structure in complex with small molecule inhibitor | 1w82 | 196 |
79 | 8en | P38 ALPHA MUTANT C162S IN COMPLEX WITH CMPD2 [N-(4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-(trifluoromethyl)benzamide] | 5mz3 | 220 |
80 | 1gk | Crystal structure of P38 kinase in complex with a pyrrole-2-carboxamide inhibitor | 3mpt | 251 |
81 | wbt | Identification of novel p38 alpha MAP Kinase inhibitors using fragment-based lead generation. | 1wbt | 340 |
82 | l09 | fragment based p38 inhibitors | 1wbn | 350 |
83 | bmu | Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding | 3o8p | 350 |
84 | gk4 | Crystal structure of P38 in complex with biphenyl amide inhibitor | 2zb1 | 480 |
85 | pqa | p38alpha MAP kinase bound to pyrazoloamine | 2bal | 490 |
86 | li2 | Identification of novel p38 alpha MAP Kinase inhibitors using fragment-based lead generation. | 1wbs | 630 |
87 | pqb | P38 Kinase Crystal Structure in complex with RO3201195 | 2gfs | 700 |
88 | df3 | Human p38 MAP Kinase in Complex with an Indole Derivative | 3iw5 | 839 |
89 | g97 | Human p38 MAP Kinase in Complex with RL40 | 3huc | 1030 |
90 | bmu | p38 MAP Kinase in Complex with Inhibitor 1 | 1kv1 | 1160 |
91 | bi5 | Human P38 MAP Kinase in Complex with Inhibitor 1a | 1zyj | 1500 |
92 | ipk | Human p38 MAP Kinase in Complex with an Imidazo-pyridine | 3iw7 | 2300 |
93 | r39 | Human p38 MAP Kinase in Complex with RL39 | 3hv6 | 2300 |
94 | p79 | P38 inhibitor-bound | 3p79 | 2300 |
95 | irg | Human p38 MAP kinase in complex with RL87 | 4dli | 2400 |
96 | pp0 | Human p38 MAP Kinase in Complex with a Benzylpiperazin-Pyrrol | 3iw6 | 3290 |
97 | msq | THE STRUCTURE OF P38 MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH 4-[3-METHYLSULFANYLANILINO]-6,7-DIMETHOXYQUINAZOLINE | 1di9 | 5000 |
98 | b11 | Two Classes of p38alpha MAP Kinase Inhibitors Having a Common Diphenylether Core but Exhibiting Divergent Binding Modes | 1zz2 | 6000 |
99 | f4c | P38alpha bound to novel DFG-out compound PF-00416121 | 3k3j | 1.25e+004 |
100 | hiz | Structure of Inactive Human p38 MAP Kinase in Complex with a Thiazole-Urea | 3iw8 | 1.34e+004 |
101 | sti | P38 in complex with Imatinib | 3hec | 3.4e+004 |
102 | nar | Human p38 MAP kinase in complex with NP-F2 and RL87 | 4eh3 | 2.92e+005 |
103 | 0ok | Human p38 MAP kinase in complex with NP-F1 and RL87 | 4eh2 | 6.92e+005 |
104 | 0om | Human p38 MAP kinase in complex with NP-F4 and RL87 | 4eh5 | 8.18e+005 |